维普期刊资源整合服务平台（V6.5）

95篇 您的检索式：作者名="Parnetti"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers显示文摘Cognitive impairment is a common clinical manifestation of multiple sclerosis,but its pathophysiology is not completely understood.White and grey matter injury together with synaptic dysfunction do play a role.The measurement of biomarkers in the cerebrospinal fluid and the study of their association with cognitive impairment may provide interesting in vivo evidence of the biological mechanisms underlying multiple sclerosis-related cognitive impairment.So far,only a few studies on this topic have been published,giving interesting results that deserve further investigation.Cerebrospinal fluid biomarkers of different pathophysiological mechanisms seem to reflect different neuropsychological patterns of cognitive deficits in multiple sclerosis.The aim of this review is to discuss the studies that have correlated cerebrospinal fluid markers of immune,glial and neuronal pathology with cognitive impairment in multiple sclerosis.Although preliminary,these findings suggest that cerebrospinal fluid biomarkers show some correlation with cognitive performance in multiple sclerosis,thus providing interesting insights into the mechanisms underlying the involvement of specific cognitive domains.	Lorenzo Gaetani Nicola Salvadori Elena Chipi Lucia Gentili Angela Borrelli Lucilla Parnetti Massimiliano Di Filippo	2021	Neural Regeneration Research2021，16，1：	2
2	Diagnosing prodromal Alzheimer’s disease: Role of CSF biochemical markers显示文摘	Lucilla Parnetti Alessia Lanari Giorgio Silvestrelli Emanuele Saggese Paolo Reboldi	2005	Mechanisms of Ageing and Development2005，，2：	2
3	Idebenone in senile dementia of Alzheimer type : a multicentre study显示文摘	Senin U Parnetti L Barbagallo-Sangiorgi G	1992	Arch Gerontol Geriatr1992，15，3：	1
4	Pharmacokinetics of iv and oral acetyl-1-carnitine in a multiple dose regimen in pa- tients with senile dementia of alzheimer type 显示文摘	Parnetti L Gaiti A Mecocci P	1992	Eur J Clin Pharmacol1992，42，1：	1
5	Multi-centre study of L-alpha glyceryl-phosphorylcholine vsST200 among patients with probable senile dementia ofAlzheimer’s type显示文摘	PARNETTI L ABATE G BARTORELLI L	1993	Drugs Aging1993，3，2：	1
6	Mild hyperhomocysteinemia is a risk factor in all etiological subtypes of stroke显示文摘	Parnetti L Caso V Santucci A	2004	Neurol Sci2004，25，1：	1
7	Hyperhomocysteinemia:a risk factor for cerebrovascular disease显示文摘	Parnetti L Caso V Amici S	2002	Clin Exp Hypertens2002，24，78：	1
8	Clinical pharmacokinetics of drugs for Alzheimer's disease 显示文摘	Parnetti L	1995	Clin Pharmacokinet1995，29，2：	1
9	Early admission to stroke unit influences clinical outcome显示文摘	Silvestrelli G Parnetti L Paciaroni M	2006	Eur J Neurol2006，13，3：	1
10	Cognitive enhancement therapy for Alzheimer's disease显示文摘	Parnetti L Senin U Mecocci P	1997	Drugs1997，53，8：	1
11	Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers显示文摘	Parnetti L Lanari A Silvestrelli G	2006	Mech Ageing Dev2006，127，：	1
12	Treatment of Alzheimer's disease:From pharmacology to a better understanding of disease pathophysiology显示文摘	Silvestrelli G Lanari A Parnetti L	2006	Mech Ageing Dev2006，127，2：	1
13	Mild Hyperhomocyst(e)inemia: A Possible Risk Factor for Cervical Artery Dissection显示文摘	Virgilio Gallai Valeria Caso Maurizio Paciaroni Gabriela Cardaioli Erland Arning Teodoro Bottiglieri Lucilla Parnetti	2001	Stroke: Journal of the American Heart Association2001，，3：	1
14	CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies显示文摘	Parnetti L Lanari A Amici S	2001	Neurol Sci2001，22，：	1
15	Early admission to stroke unit im'luences clinical outcome 显示文摘	Silvestrelli G Parnetti L Paciaroni M	2006	Eur J Neurol2006，13，：	1
16	Multicentre study of L-alpha-glyeerylphosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type 显示文摘	Parnetti L Abate G Bartorelli L	1993	Drugs Aging1993，3，2：	1
17	Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke显示文摘	Parnetti L Caso V Santucci A	2004	Neurol Sci2004，25，：	1
18	Cognitive en2hancement therapy for Alzheimer's disease显示文摘	Senin U and Necocci P	1997	Drugs1997，53，5：	1
19	Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group显示文摘	Parnetti L Meeocci P Petrini A	1989	Neuropsychobiology1989，22，2：	1
20	Treatment of Alzheimer' s disease: from pharmacology to a better understanding of disease pathophysiology显示文摘	Silvestrelli G Lanari A Parnetti L	2006	Mech Ageing Dev2006，127，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示